[ExI] note from 23andme

BillK pharos at gmail.com
Sat Dec 7 10:08:03 UTC 2013


On Sat, Dec 7, 2013 at 5:25 AM, spike wrote:
> Hey check this:
> Comments?
>
>
> Dear 23andMe Customers,
>
> I'm writing to update you on our conversation with the U.S. Food and Drug Administration
> and how it impacts you.
>
> If you are a customer whose kit was purchased before November 22, 2013,
> your 23andMe experience will not change. You will be able to access both
> ancestry and health-related information as you always have.
>
> 23andMe has complied with the FDA's directive and stopped offering new consumers
> access to health-related genetic results while the company moves forward with
> the agency's regulatory review processes. Be sure to refer to our 23andMe blog for updates.
>
>


And now they are being sued.
<http://arstechnica.com/science/2013/12/23andme-bows-to-fda-drops-all-medical-information-from-new-tests/>

Quote:
23andMe bows to FDA, drops all medical information from new tests
Company had already pulled ads, and now it faces a class-action lawsuit.
by John Timmer - Dec 6 2013

After a partial attempt to get the Food and Drug Administration to
ease up on its complaints, the personal genetics company 23andMe took
a rather substantial step yesterday: it pulled all medically relevant
information from its site, replacing its normal home page with a
disclaimer.

A class-action lawsuit was filed against 23andMe in a California
federal court, claiming that everyone who purchased one of the test
kits did so under fraudulent promises. Noting that 23andMe promised
medical information but hadn't validated those claims to the FDA's
satisfaction, the suit claims that the company's product "does none of
those things, and the results it provides are not supported by any
scientific evidence."
------------


(Of course, in sue-happy USA that doesn't necessarily mean the action
has much chance of success. But 23andMe is well-financed and the
complainants may be hoping to get paid a lot of money just to go
away).


BillK



More information about the extropy-chat mailing list